Trial 1 | Trial 2 | Trial 3 | ICC (2vs3) | p-value (Anova) | |
---|---|---|---|---|---|
Healthy participants | |||||
Dominant hand | 44.3 ± 16.20 | 51 ± 16.09† | 54.5 ± 17.02 | 0.89* | < 0.001 |
Non dominant hand | 47.8 ± 18.23 | 53.7 ± 19.28† | 55.2 ± 22.3 | 0.94* | < 0.001 |
Patients with stroke | |||||
Less affected hand | 24.5 ± 9.06 | 31.9 ± 10.31† | 34.5 ± 9.36 | 0.84* | < 0.001 |
Paretic hand | 17 [14–29] | 18 [13.5–30]† | 25 [17–33] | 0.87* | 0.04 |